Skip Navigation LinksHome > Current Issue > Editorial introductions
Text sizing:
A
A
A
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0000000000000084
Editorial introductions

Editorial introductions

Section Editor(s): Justice, Amy C.; Falutz, Julian

Free Access

Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.

Back to Top | Article Outline

SECTION EDITORS

Amy C. Justice

Amy C. Justice, MD, PhD is Section Chief of General Medicine at the VA Connecticut Healthcare System and Professor of Medicine and Public Health at Yale University, USA, where she chairs the Center for Interdisciplinary Research on AIDS Clinical and Health Services Research Core. She trained at Harvard College (BA), Yale Medical School (MD), University of Pennsylvania (MSCE), and the Wharton School (PhD). She completed a residency in medicine and the Robert Wood Johnson Program Clinical Scholars fellowship at University of Pennsylvania. She has had the privilege of working closely with notable mentors including: Dr Alvan Feinstein, Drs Suzanne and Robert Fletcher, Dr Sankey Williams, and Dr Seth Landefeld.

Amy C. Justice...
Amy C. Justice...
Image Tools

Dr Justice is the Principal Investigator of the Veterans Aging Cohort Study (VACS), a 17 year, ongoing, longitudinal study of more than 140,000 United States veterans with and without HIV infection funded by the National Institutes of Health (NIH). Her research uses epidemiology, informatics, and operations research to study the complex and interacting roles of aging, substance use, treatment, adherence, and medical and psychiatric comorbid illness in determining patient relevant outcomes for people aging with and without HIV infection. She is particularly interested in issues of multimorbidity, polypharmacy, and frailty. She led efforts to develop and validate the VACS Index and the HIV Symptom Index. Her work is largely based on data from the Veterans Affairs Healthcare System Electronic Medical Record enhanced with data from multiple outside sources and a tissue repository supporting translational research including genetic studies. VACS contributes data to three multinational cross cohort collaborations: The Antiretroviral Therapy Cohort Collaboration (ART-CC), the North American AIDS Cohort Collaboration (NA-ACCORD), and HIV Causal. Dr Justice serves as a member of the Steering and/or Executive Committees for each of these collaborations and has spearheaded major analytic projects using data from each of these groups. She has presented work on Aging and HIV at the United Nations, The International AIDS Society, the White House, Congress, and the National Institutes of Health (NIH). She advises the National Cancer Institute as a member of the ad hoc Subcommittee on HIV and AIDS Malignancy and the HIV and Aging Working Group, NIH Office of AIDS Research. She is a standing member of the AIDS Clinical Studies & Epidemiology NIH study section and was selected one of 100 Most Influential Professors of Public Health in 2012.

Back to Top | Article Outline
Julian Falutz

Julian Falutz MD, is Associate Professor of Medicine at McGill University, Director of the HIV Metabolic Clinic and founding Director of the Comprehensive HIV and Aging Initiative (CHAI) clinic at the Chronic Viral Infection Service at the McGill University Health Center in Montreal, Canada. He attended the McGill University School of Medicine from 1978 to 1982, his graduation coinciding with the beginning of the HIV epidemic. After completing residency in general internal medicine he pursued subspecialty studies in geriatrics while continuing to provide clinical service to HIV patients. He started on staff at the Montreal General Hospital in 1987 in both the Division of Geriatrics, where is he currently Senior Physician, and the Immune Deficiency Treatment Center, devoting his clinical activities to the care of the elderly and to comprehensive care of HIV patients.

Julian Falutz...
Julian Falutz...
Image Tools

His research interests in HIV involve the interaction of nutrition, metabolic complications, aging and their impact on HIV disease. After a sabbatical in the early 1990's at the UCLA Center for AIDS Research and Evaluation Unit he focussed his research on studies of the use of growth hormone, initially for the AIDS wasting syndrome, and subsequently on the investigation of role of these agents in the HIV associated lipodystrophy syndromes. He played a key role in initiating the study of a synthetic recombinant human growth hormone analogue (tesamorelin) for the treatment of HIV/HAART associated visceral adiposity. He was the co-principle investigator for a series of multinational studies of this agent which culminated in its being approved in both the United States and Canada for use in this important, ongoing complication. He has initiated and participated in numerous clinical studies on the assessment of metabolic complications and published extensively in both this area and on clinical aspects of HIV and aging.

As the clinical characteristics of the HIV epidemic have evolved his clinical and research activities have expanded and he is collaborating on multicentre studies aimed at understanding the process of frailty in HIV patients, including the contribution of body composition changes to the development of frailty, as well as cardiovascular complications in aging HIV patients. The CHAI clinic focuses on the evaluation and management of patients aging with HIV.

A dedicated educator, he has been a leader in developing interdisciplinary HIV teaching programs for medical and allied health science students and has been active in public and academic educational programs related to HIV disease. He has organized a successful HIV elective program at McGill University, coordinating the training of both local students and residents and others from around the world. He currently serves on the Scientific Committees of the International Workshop on Co-morbidities and Adverse Drug Reactions in HIV as well as the Workshop on HIV and Aging. He is also a reviewer for several major infectious diseases and HIV related journals.

© 2014 Lippincott Williams & Wilkins, Inc.

Login